|
| Date |
Time |
Place |
Session / Title |
Role |
|
| April 29 |
7:00 AM - 8:00 AM |
Coronary Theater, Level 1 |
Bioresorbable Vascular Scaffolds |
Moderator |
| April 29 |
8:15 AM - 9:25 AM |
Main Arena, Level 3 |
Live Case Session - USA |
Moderator |
| April 29 |
9:40 AM - 9:45 AM |
Main Arena, Level 3 |
Opening of TCTAP 2015
Congratulatory Remark |
Speaker |
| April 29 |
10:00 AM - 10:30 AM |
Interview Lounge, Level 2 |
Dual Antiplatelet Therapy for Coronary Artery Disease |
Moderator |
| April 29 |
11:00 AM - 11:45 AM |
Main Arena, Level 3 |
TCT @ TCTAP 2015: Controversies and Hot Topics |
Moderator |
| April 29 |
11:15 AM - 11:25 AM |
Main Arena, Level 3 |
TCT @ TCTAP 2015: Controversies and Hot Topics
Bioresorbable Scaffolds in a "Nutshell": Updates and Expectations |
Lecturer |
| April 29 |
12:45 PM - 1:00 PM |
Coronary Theater, Level 1 |
The 4th Revolution in PCI (Bioresorbable Vascular Scaffolds)
Evolution, BVS Unique Benefits, Clinical Perspectives on Angina |
Lecturer |
| April 29 |
2:00 PM - 3:17 PM |
Room 104, Level 1 |
Imaging & Physiology Summit |
Moderator |
| April 29 |
2:48 PM - 2:56 PM |
Room 104, Level 1 |
Imaging & Physiology Summit
Focal Treatment of Vulnerable Plaque: Stents, Scaffolds and Prospect II |
Lecturer |
|
|
|
|
|
|
|
|
|
|
| April 29 |
4:30 PM - 5:00 PM |
Interview Lounge, Level 2 |
How to Detect and Treat Vulnerable Plaques? |
Interviewee |
| April 30 |
8:52 AM - 9:00 AM |
Room 104, Level 1 |
Eye on ACS Trials: Making the Right Choice
UFH Versus Bivalirudin: Which One Should I Use? |
Lecturer |
| April 30 |
9:30 AM - 10:54 AM |
Coronary Theater, Level 1 |
Coronary Session III. Late Breaking Clinical Trials & Leading Clinical Trials from Asan Medical Center |
Panelist |
| April 30 |
9:38 AM - 9:44 AM |
Coronary Theater, Level 1 |
Coronary Session III. Late Breaking Clinical Trials & Leading Clinical Trials from Asan Medical Center |
Discussant |
| April 30 |
10:34 AM - 10:40 AM |
Coronary Theater, Level 1 |
Coronary Session III. Late Breaking Clinical Trials & Leading Clinical Trials from Asan Medical Center |
Discussant |
| April 30 |
12:45 PM - 1:45 PM |
Endovascular & Structural Heart Theater, Level 1 |
Ticagrelor: Breaking the Limit in ACS |
Panelist |
| April 30 |
12:50 PM - 1:05 PM |
Endovascular & Structural Heart Theater, Level 1 |
Ticagrelor: Breaking the Limit in ACS
PLATO: Impact on the Management of ACS and Personalizing Treatment with Ticagrelor |
Lecturer |
| April 30 |
2:00 PM - 3:00 PM |
Coronary Theater, Level 1 |
Live Case Session VI |
Moderator |
| April 30 |
3:00 PM - 3:12 PM |
Coronary Theater, Level 1 |
Coronary Session V
Vulnerable Plaque Detection and Treatment: PROSPECT II and PROSPECT ABSORB |
Lecturer |
| April 30 |
3:00 PM - 3:30 PM |
Coronary Theater, Level 1 |
Coronary Session V |
Panelist |
| April 30 |
3:45 PM - 3:55 PM |
Endovascular & Structural Heart Theater, Level 1 |
I. Valvular Disease Session
Future Roadmap of the Mitral Valve Therapies |
Lecturer |
|
